DNA
Ginkgo Bioworks Holdings
11.30$
-1.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -51.9% | +30.9% | +141.0% | +37.6% | -1.0% | +77.9% | +91.3% | +13.4% | -14.1% | -54.1% | +48.0% | -17.9% | -0.2% | -31.2% | -37.3% | +9.2% | +48.1% | +58.4% | -50.8% | +10.2% | +2.7% | -21.7% | -14.0% | -41.7% | +3.5% | – | |
| – | – | – | +682.5% | +71.2% | -27.8% | +30.3% | +198.5% | +28.3% | -25.2% | -61.4% | +22.6% | -26.0% | -19.1% | -61.7% | -4.5% | +39.2% | +49.1% | -27.2% | -3.7% | +25.2% | +23.0% | -13.6% | -163.7% | – | -89.2% | – | |
| – | -51.9% | +13.5% | +57.9% | +12.0% | +30.0% | +108.5% | +48.1% | +1.3% | -2.7% | -48.3% | +63.1% | -14.3% | +7.1% | -22.4% | -42.0% | +2.1% | +47.8% | +86.1% | -56.7% | +6.0% | -4.1% | -25.1% | +59.6% | -91.4% | +415.4% | – | |
| – | +6.7% | +11.8% | +69.6% | -2.6% | -12.7% | +1.9% | +1,757.8% | -67.2% | -10.4% | -9.9% | -30.7% | -10.2% | -11.3% | +8.6% | -25.3% | +16.6% | -1.6% | -42.6% | -0.8% | -7.1% | -24.7% | +29.9% | -27.7% | -0.4% | -7.4% | – | |
| – | +36.3% | +10.4% | +30.8% | +38.8% | +92.1% | -15.9% | +2,599.1% | -44.4% | +0.8% | -0.7% | -72.1% | -8.2% | -8.2% | -19.8% | +8.8% | -21.2% | -5.7% | -21.1% | +9.6% | -14.4% | -11.8% | +3.9% | +2.4% | -17.8% | -18.6% | – | |
| – | +12.0% | +11.5% | +61.3% | +4.6% | +11.6% | -5.2% | +2,055.0% | -57.1% | -3.9% | -4.4% | -56.6% | -9.4% | -10.0% | +35.8% | -38.4% | +0.2% | +28.4% | -49.4% | +2.7% | -9.1% | -19.9% | +15.7% | -3.2% | -33.3% | +2.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -0.3% | -19.5% | +0.6% | +35.8% | -15.1% | -27.9% | +321.7% | +0.0% | +680.1% | -56.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.7% | +0.0% | +33.3% | -2,087.5% | – | – | – | – | – | – | – | – | -18.3% | -132.8% | – | – | +512.9% | -297.4% | – | – | -421.6% | – | -64,400.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.